Jafron participated in the 38th Annual Congress of the European Society of Intensive Care Medicine (ESICM 2025), presenting its comprehensive blood purification portfolio to clinicians and partners from around the world. As a leading innovator in the field, Jafron highlighted its latest technological advancements and continued progress toward global expansion. This year’s presence was also aligned with Jafron’s slogan, “Caring for Acute Phase,” reflecting the company’s focus on supporting patients during the critical stages of illness and advancing Multi-Organ Support Therapy (MOST).

The exhibit featured a broad range of solutions, including hemoadsoption cartridges, plasma separators, dialyzers, and integrated blood purification devices. The upcoming AMOS Continuous Blood Purification Equipment was also introduced through dedicated booth poster displays, drawing strong interest and inquiries from attending experts.

Throughout the three-day event, the Jafron booth welcomed nearly 400 intensivists and medical specialists. Visitors expressed keen interest in Jafron’s technologies and shared positive clinical insights. Several international experts also exchanged real-world experiences with Jafron products, underscoring their growing adoption in critical care settings.

Jafron remains committed to driving innovation and collaborating with the global medical community. By advancing high-quality blood purification technologies, the company aims to bring the benefits of innovations developed and manufactured in China to more patients worldwide.